Progressive Care Inc. Garners International News Coverage in Top Pharmacy Trade Publication for Its Efforts to Battle Opioid Epidemic

September 13, 2018

MIAMI, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in top pharmacy industry publication World Pharma Today around the company’s efforts to combat the nationwide opioid epidemic.In a contributed article published August 20, 2018, in World Pharma Today, Mars explores the history of the opioid crisis and shares her perspective on what more can be done to provide patients with better access to pain management alternatives in lieu of prescription opioid medications. The article, titled “Risking Addiction for Relief: Is There a Better Alternative to Opioids?”, also appears in the publication’s August print issue.In the piece, Mars writes: “Opioids may still be necessary in some cases but should generally be avoided whenever possible. Through communication, outreach and education about alternatives for pain management, pharmacists can move toward a healthcare industry that is less dependent on opioid medications.”“We are honored to have Progressive Care’s efforts around the opioid crisis highlighted in these industry publications,” said S. Parikh Mars, CEO of Progressive Care Inc. “The opioid epidemic continues to be a serious issue causing incredible damage to patients and communities across the U.S. We hope that this media coverage brings more light to the rising problem, as well as increases awareness of the help people can get through PharmCo’s customized opioid alternative solutions for patients.”Progressive Care has remained committed to making efforts to battle the opioid epidemic plaguing the nation. In June of 2018, the company launched a new program designed to educate patients and providers on treatment alternatives to opioids available through the company. PharmCo continues to offer its network the most current pharmacological information, a team of pharmacists and technicians highly trained in pain management and compounding, and provides physician in-services, educational seminars, patient consultation and customized medicinal pain management solutions.The recent media coverage comes after the company’s efforts to provide its network with more healthcare informational resources through PharmCo Pharmacy. Additional commentary from Progressive Care’s CEO about the company and industry as a whole can be found on the Progressive Care blog and PharmCo blog.For more immediate updates on the company’s media coverage, connect with Progressive Care and PharmCo on social media:Progressive Care Inc., LLC Progressive Care Inc.Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.Cautionary Statement Regarding Forward Looking StatementsStatements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.Investor Relations Contact:Armen Karapetyan, Progressive CareSenior Advisor Business DevelopmentArmen@progressivecareus.comwww.progressivecareus.comwww.pharmcopharmacy.comPublic Relations Contact:Tory Patterson, CMW MediaTory@cmwmedia.comwww.cmwmedia.comWeb and Application Development Contact:Marcello Jaspan, Mass Ventures

Investors' Presentation